FENG CHI (Taiwan) Today

6744 -  Taiwan Stock  

TWD 26.95  0.75  2.86%

FENG CHI is selling for under 26.95 as of the 20th of September 2021; that is 2.86 percent up since the beginning of the trading day. The stock's lowest day price was 26.0. FENG CHI has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for FENG CHI BIOTECH are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2021 and ending today, the 20th of September 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 24
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

FENG CHI Stock Profile

Feng Chi Biotech Corp. provides preimplantation genetic testing, prenatal testing, life science, newborn screening, foodpharmaceutical microbiological testing, and medical translational research services. FENG CHI operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 31 people. more on FENG CHI
On 26th of July 2021 FENG CHI paid NT$ 1.15 per share dividend to its current shareholders
Legal NameFENG CHI BIOTECH
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of FENG CHI's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldFairly Valued
FENG CHI BIOTECH (6744) is traded on Taiwan OTC Exchange in Taiwan and employs 31 people. The company currently falls under 'Small-Cap' category with current market capitalization of 403.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate FENG CHI's market, we take the total number of its shares issued and multiply it by FENG CHI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. FENG CHI BIOTECH operates under Healthcare sector and is part of Biotechnology industry. The entity has 15.4 M outstanding shares. FENG CHI BIOTECH has accumulated about 219.26 M in cash with 39.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.24.
Check FENG CHI Probability Of Bankruptcy

FENG CHI Stock Price Odds Analysis

What are FENG CHI's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of FENG CHI jumping above the current price in 90 days from now is about 80.15%. The FENG CHI BIOTECH probability density function shows the probability of FENG CHI stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon FENG CHI has a beta of 0.4689. This suggests as returns on the market go up, FENG CHI average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding FENG CHI BIOTECH will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. FENG CHI BIOTECH is significantly underperforming DOW.
 Odds Down 26.95HorizonTargetOdds Up 26.95 
19.63%90 days
 26.95 
80.15%
Based on a normal probability distribution, the odds of FENG CHI to move above the current price in 90 days from now is about 80.15 (This FENG CHI BIOTECH probability density function shows the probability of FENG CHI Stock to fall within a particular range of prices over 90 days) .

FENG CHI BIOTECH Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. FENG CHI market risk premium is the additional return an investor will receive from holding FENG CHI long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FENG CHI. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although FENG CHI's alpha and beta are two of the key measurements used to evaluate FENG CHI's performance over the market, the standard measures of volatility play an important role as well.

FENG CHI Stock Against Markets

Picking the right benchmark for FENG CHI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in FENG CHI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for FENG CHI is critical whether you are bullish or bearish towards FENG CHI BIOTECH at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in FENG CHI without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module
Please continue to Trending Equities. Note that the FENG CHI BIOTECH information on this page should be used as a complementary analysis to other FENG CHI's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Tools for FENG CHI Stock

When running FENG CHI BIOTECH price analysis, check to measure FENG CHI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FENG CHI is operating at the current time. Most of FENG CHI's value examination focuses on studying past and present price action to predict the probability of FENG CHI's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move FENG CHI's price. Additionally, you may evaluate how the addition of FENG CHI to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go